Skip to NavigationSkip to content

News

0
Ascletis Pharma has announced the dosing of the first patient in the Phase III registration clinical trial of ASC40, combined with bevacizumab, for...
0
Pfizer CEO Albert Bourla has commented that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the pandemic.
0
NICE have updated the Technology Appraisal Guidance (TAG) for Lokelma (sodium zirconium cyclosilicate SZC) in the treatment of adult patients with...
0
The FDA has granted expedited approval of a supplemental new drug application (sNDA) for Veklury (remdesivir) for he treatment of non-hospitalised...

Features

The COVID-19 pandemic had a significant impact on the diabetes care landscape. Ana Ovey delves into the unique challenges...